2024 annual financial data
ProQR Therapeutics 2024 Net margin
Direct answer
Net margin was -146.86%.
Operating income was -30.47M EUR and net income was -27.76M EUR.
Operating cash flow was -36.39M EUR.
Get free ProQR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 18.91M EUR
- Operating income
- -30.47M EUR
- Net income
- -27.76M EUR
- Operating cash flow
- -36.39M EUR